Cesarean Section with Sterilization with MCC DRG Reimbursement

DRG 783 encompasses cesarean delivery combined with sterilization when a Major Complication or Comorbidity is documented, reflecting increased clinical complexity. This classification affects inpatient reimbursement because severity-adjusted Diagnosis-Related Group assignment increases payment relative to less complex obstetric groups.

DRG 783 Overview

DRG 783 covers inpatient cases involving cesarean section with concurrent sterilization procedures when a Major Complication or Comorbidity is present. This Diagnosis-Related Group captures higher resource use due to the combination of operative obstetric care and additional complexity from serious medical or surgical conditions. It matters for Medicare payment because the presence of a Major Complication or Comorbidity increases the relative weight and reimbursement compared with lower-severity groups. Accurate coding of principal procedure, sterilization, and comorbid conditions determines assignment to this Diagnosis-Related Group and influences inpatient payment.

DRG 783 Overview

Trials evaluating perioperative protocols to reduce maternal morbidity in cesarean deliveries with concurrent sterilization: randomized or pragmatic studies comparing enhanced recovery protocols, optimized antibiotic and thromboprophylaxis regimens, and blood loss–minimization strategies specifically in patients undergoing cesarean section plus tubal sterilization. These studies focus on antepartum and intraoperative care for women delivering by cesarean who elect or require sterilization, many of whom may have comorbidities or emergent indications that increase complication risk. Results are highly relevant to clinicians for refining perioperative pathways and to payers because reductions in complications, length of stay, and readmissions directly affect resource use and DRG-related costs.
Comparative effectiveness research on surgical technique and timing of sterilization at cesarean delivery: observational cohort studies or randomized trials comparing different sterilization methods (for example, partial salpingectomy versus clip or ring techniques) and the timing/approach (immediate at cesarean versus deferred postpartum) in diverse obstetric populations. These studies examine effectiveness, procedure-related complication rates, operative time, and subsequent reproductive outcomes among women undergoing cesarean delivery who desire permanent contraception. Findings inform surgical best practices, consent and scheduling decisions for providers, and help payers anticipate downstream utilization and potential cost differences associated with reoperation or sterilization failure.
Post-discharge outcomes and health-services research on recovery, contraceptive counseling uptake, and readmission after cesarean with sterilization: prospective cohort studies and quality-improvement evaluations tracking maternal functional recovery, wound complications, postoperative pain control, adherence to follow-up visits, and patient-reported satisfaction with contraceptive counseling. The population includes postpartum women after cesarean with sterilization, including subgroups at higher risk for social determinants–related gaps in care. This research is important to providers to target discharge planning and outpatient care coordination, and to payers because improving transition-of-care metrics and reducing preventable readmissions can lower overall expenditures under the DRG payment model.

Trials evaluating perioperative protocols to reduce maternal morbidity in cesarean deliveries with concurrent sterilization: randomized or pragmatic studies comparing enhanced recovery protocols, optimized antibiotic and thromboprophylaxis regimens, and blood loss–minimization strategies specifically in patients undergoing cesarean section plus tubal sterilization. These studies focus on antepartum and intraoperative care for women delivering by cesarean who elect or require sterilization, many of whom may have comorbidities or emergent indications that increase complication risk. Results are highly relevant to clinicians for refining perioperative pathways and to payers because reductions in complications, length of stay, and readmissions directly affect resource use and DRG-related costs.
Comparative effectiveness research on surgical technique and timing of sterilization at cesarean delivery: observational cohort studies or randomized trials comparing different sterilization methods (for example, partial salpingectomy versus clip or ring techniques) and the timing/approach (immediate at cesarean versus deferred postpartum) in diverse obstetric populations. These studies examine effectiveness, procedure-related complication rates, operative time, and subsequent reproductive outcomes among women undergoing cesarean delivery who desire permanent contraception. Findings inform surgical best practices, consent and scheduling decisions for providers, and help payers anticipate downstream utilization and potential cost differences associated with reoperation or sterilization failure.
Post-discharge outcomes and health-services research on recovery, contraceptive counseling uptake, and readmission after cesarean with sterilization: prospective cohort studies and quality-improvement evaluations tracking maternal functional recovery, wound complications, postoperative pain control, adherence to follow-up visits, and patient-reported satisfaction with contraceptive counseling. The population includes postpartum women after cesarean with sterilization, including subgroups at higher risk for social determinants–related gaps in care. This research is important to providers to target discharge planning and outpatient care coordination, and to payers because improving transition-of-care metrics and reducing preventable readmissions can lower overall expenditures under the DRG payment model.

OpenPayer

Summary & Overview

Cesarean Section with Sterilization with MCC: Inpatient Reimbursement Overview

DRG 783 Overview

OpenPayer

Summary & Overview

Cesarean Section with Sterilization with MCC: Inpatient Reimbursement Overview

DRG 783 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes